Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer

BACKGROUND: Patients (pts) with metastatic rectal cancer and symptomatic primary, require local and systemic control. Chemotherapy used during chemoradiotherapy (CRT) is adequate for radiosensitisation, but suboptimal for systemic control. The aim of this phase II study was to assess tolerability, l...

Descripción completa

Detalles Bibliográficos
Autores principales: Michael, M, Chander, S, McKendrick, J, MacKay, J R, Steel, M, Hicks, R, Heriot, A, Leong, T, Cooray, P, Jefford, M, Zalcberg, J, Bressel, M, McClure, B, Ngan, S Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229632/
https://www.ncbi.nlm.nih.gov/pubmed/25211659
http://dx.doi.org/10.1038/bjc.2014.487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229632/
https://www.ncbi.nlm.nih.gov/pubmed/25211659
http://dx.doi.org/10.1038/bjc.2014.487

Ejemplares similares